CoChat
Sign Up
Cited by 152Pancreatic and Hepatic Oncology ResearchMRI in cancer diagnosisPancreatitis Pathology and Treatment

The DOI matches its Crossref record; 18 of the 19 references it cites were found in a registry or an index.

Magnetic Resonance Imaging Surveillance Detects Early-Stage Pancreatic Cancer in Carriers of a p16-Leiden Mutation

Vasen, Hans F.A., Wasser, Martin, van Mil, Anneke, Tollenaar, Rob A., Konstantinovski, Marja, Gruis, Nelleke A., Bergman, Wilma, Hes, Frederik J., Hommes, Daniel W., Offerhaus, G. Johan A., Morreau, Hans, Bonsing, Bert A., de Vos tot Nederveen Cappel, Wouter H.·2011·Gastroenterology
DOI 10.1053/j.gastro.2010.11.048
Open this paper in CoChat — free account

Abstract

Background & aims Surveillance of high-risk groups for pancreatic cancer might increase early detection and treatment outcomes. Individuals with germline mutations in p16-Leiden have a lifetime risk of 15% to 20% of developing pancreatic cancer. We assessed the feasibility of detecting pancreatic cancer at an early stage and investigated the outcomes of patients with neoplastic lesions.Methods Individuals with germline mutations in p16-Leiden (N = 79; 31 male; mean age, 56 years; range, 39-72 years) were offered annual surveillance by magnetic resonance imaging (MRI) and magnetic resonance cholangiopancreatography (MRCP). Those found to have neoplastic lesions were offered options for surgery or intensive follow-up. Individuals found to have possible neoplastic lesions were examined again by MRI/MRCP within 2 to 4 months.Results After a median follow-up period of 4 years (range, 0-10 years), pancreatic cancer was diagnosed in 7 patients (9%). The mean age at diagnosis was 59 years (range, 49-72 years). Three of the tumors were present at the first examination, and 4 were detected after a negative result in the initial examination. All 7 patients had a resectable lesion; 5 underwent surgery, 3 had an R0 resection, and 2 had lymph node metastases. Possible precursor lesions (ie, duct ectasias, based on MRCP) were found in 9 individuals (11%).Conclusions MRI/MRCP detects small, solid pancreatic tumors and small duct ectasias. Although surveillance increases the rate of resectability, carriers of a p16-Leiden mutation develop aggressive tumors.

Overview

Integrity signals

Registry

Crossref · 10.1053/j.gastro.2010.11.048

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

1 of the 19 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

See all 152

Related

See all

Metadata

Authors
Vasen, H. F. A., Wasser, M., van Mil, A., Tollenaar, R. A., Konstantinovski, M., Gruis, N. A., Bergman, W., Hes, F. J., Hommes, D. W., Offerhaus, G. J. A., Morreau, H., Bonsing, B. A., & de Vos tot Nederveen Cappel, W. H.
Affiliations
  • Leiden University Medical Center (NL)
  • University Medical Center Utrecht (NL)
Corresponding author
Vasen, Hans F.A.
ORCID
Venue
Gastroenterology
Publisher
Elsevier BV
Published
2011-03
Volume
140
Issue
3
Pages
850-856
ISSN
0016-5085 (ISSN-L)
DOI
10.1053/j.gastro.2010.11.048
OpenAlex
W2066851924
Cited by
152
References
19
Citations by year
2026: 3 · 2025: 1 · 2024: 7 · 2023: 3 · 2022: 10 · 2021: 5 · 2020: 7 · 2019: 11 · 2018: 13 · 2017: 11 · 2016: 14 · 2015: 16 · 2014: 17 · 2013: 9 · 2012: 19
FWCI
5.37
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • Gastroenterology (publishedVersion)
  • PubMed (publishedVersion)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
  • Leiden Repository (Leiden University) (submittedVersion)
  • VUBIR (Vrije Universiteit Brussel) (submittedVersion)
Topics
  • Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › MRI in cancer diagnosis
  • Health Sciences › Medicine › Surgery › Pancreatitis Pathology and Treatment
Keywords
pancreatic cancer, germline mutation carriers, cancer surveillance, early detection, magnetic resonance imaging, magnetic resonance cholangiopancreatography, duct ectasia, tumor resectability, lymph node metastasis
MeSH terms
Adenocarcinoma, Adult, Aged, Feasibility Studies, Female, Humans, Magnetic Resonance Imaging, Male, Mass Screening, Middle Aged, Neoplasm Staging, Netherlands, Pancreas, Pancreatic Neoplasms, Phenotype, Precancerous Conditions, Predictive Value of Tests, Prognosis, Registries, Time Factors, Germ-Line Mutation, Genes, p16, Genetic Predisposition to Disease, Cholangiopancreatography, Magnetic Resonance, Early Detection of Cancer

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review